创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Brain in situ model, a unique tool to accurately simulate brain diseases

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-03 13:27
  • Views:

(Summary description)In the field of neuroscience, the study of brain diseases has always been a great challenge. Due to their complex and elusive nature, it is often difficult for traditional research methods to accurately simulate the true response of brain tissue. However, InnoModels' in situ brain models have revolutionized the field.

InnoModels Biotechnology: Brain in situ model, a unique tool to accurately simulate brain diseases

(Summary description)In the field of neuroscience, the study of brain diseases has always been a great challenge. Due to their complex and elusive nature, it is often difficult for traditional research methods to accurately simulate the true response of brain tissue. However, InnoModels' in situ brain models have revolutionized the field.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-04-03 13:27
  • Views:
Information

In the field of neuroscience, the study of brain diseases has always been a great challenge. Due to their complex and elusive nature, it is often difficult for traditional research methods to accurately simulate the true response of brain tissue. However, InnoModels' in situ brain models have revolutionized the field.
Highly realistic simulation environment: InnoModels' in situ brain models are known for their high degree of realism. The model accurately simulates the microstructure and function of human brain tissue, including key components such as neurons, synapses, blood vessels and glial cells. This allows researchers to study the onset and progression of brain diseases in a near-realistic physiological environment.
Individualized customization capability: The etiology and pathological mechanisms of brain diseases vary from person to person, making personalized treatment a key focus of research. InnoModels' in-situ brain models have excellent customization capabilities, allowing it to tailor the model to meet research needs or the pathological characteristics of a specific patient. This customization provides researchers with more precise experimental tools and helps promote the development of personalized medicine.

 


Multi-scale analysis capability: Brain disease research involves multiple scales of analysis, including molecular, cellular, tissue and overall. InnoModels' brain in situ model has the ability to analyze at multiple scales, allowing for in-depth research on brain diseases at different levels. This ability to analyze at multiple scales provides researchers with a comprehensive view and helps reveal the complexity and diversity of brain diseases.
Powerful Data Integration and Processing Capabilities: In the study of brain diseases, data integration and processing are crucial. InnoModels' brain in situ model is equipped with an advanced data processing system that can collect and analyze experimental data in real time. This data-driven research approach not only improves the efficiency and accuracy of experiments, but also helps researchers discover new treatments and drug targets.
Wide Application Prospects: InnoModels' in situ brain model has wide application prospects in the field of neuroscience. It can be used to study the occurrence mechanism of various brain diseases, drug screening and efficacy evaluation. In addition, this model can be used to train doctors and neurosurgeons to improve their surgical skills and experience.
In summary, with its highly realistic simulation environment, personalized customization capability, multi-scale analysis ability, and powerful data integration and processing capability, the brain in-situ model from InnoModels Biotechnology provides a unique tool for the research and treatment of brain diseases. With the continuous advancement of technology and the expansion of application scope, it is believed that this unique model will play an even more important role in the field of neuroscience and make greater contributions to the health of mankind.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司